par
Sean Ruck, Contributing Editor | November 18, 2015
HCB News: Are there any current studies or new technology you’re particularly excited about?
RA: There are a number of terrific advances under development at the current time. Hyperpolarized C13 brings a new family of interesting contrast agents for MR studies. Steerable catheters in interventional MR provide new tools for reaching very small inaccessible blood vessels. MR elastography promises to provide new insight into a host of diseases. Magnetoencephalography has shown terrific discrimination in the brain with resolutions down to milliseconds. And molecular and functional imaging holds great promise in the era of precision medicine.
Back to HCB News
Ad Statistics
Times Displayed: 23122
Times Visited: 497 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money